| Influence of Semaglutide on Pharmacokinetics and Pharmacodynamics of Warfarin and Pharmacokinetics of Metformin in Healthy Subjects (NCT02022254) | Novo Nordisk A/S | 2013-12-17 |
| Treatment of SCID Due to ADA Deficiency With Autologous Transplantation of Cord Blood or Hematopoietic CD 34+ Cells After Addition of a Normal Human ADA cDNA by the EFS-ADA Lentiviral Vector (NCT02022696) | National Human Genome Research Institute (NHGRI) | 2013-12-16 |
| Pomalidomide After Combination Chemotherapy in Treating Patients With Newly Diagnosed Acute Myeloid Leukemia or High-Risk Myelodysplastic Syndrome (NCT02029950) | National Cancer Institute (NCI) | 2013-12-16 |
| A Study to Evaluate the Safety and Pharmacology of DNIB0600A in Participants With Platinum-Sensitive Ovarian Cancer or Non-Squamous Non-small Cell Lung Cancer (NCT01995188) | Genentech, Inc. | 2013-12-16 |
| A Trial Investigating Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of a Single Dose of Long-acting Growth Hormone (Somapacitan) Compared to Daily Dosing of Norditropin® SimpleXx® in Children With Growth Hormone Deficiency (NCT01973244) | Novo Nordisk A/S | 2013-12-16 |
| Study to Evaluate the Pharmacokinetics of Velpatasvir in Participants With Normal Renal Function and Severe Renal Impairment (NCT02002767) | Gilead Sciences | 2013-12-16 |
| A Study of GDC-0853 in Patients With Resistant B-Cell Lymphoma or Chronic Lymphocytic Leukemia. (NCT01991184) | Genentech, Inc. | 2013-12-16 |
| Bioavailability Study of Candesartan Cilexetil 16mg Tablet Under Fasting Conditions (NCT02006602) | GlaxoSmithKline | 2013-12-13 |
| Ublituximab in Combination With TGR-1202 +/- Ibrutinib or Bendamustine in Patients With B-cell Malignancies (NCT02006485) | TG Therapeutics, Inc. | 2013-12-13 |
| Enzalutamide and Mifepristone in Treating Patients With Metastatic Hormone Resistant Prostate Cancer (NCT02012296) | University of Chicago | 2013-12-13 |
| First-in-Human Dose Escalation Trial in Subjects With Advanced Malignancies (NCT01971515) | EMD Serono | 2013-12-13 |
| Pharmacokinetics, Safety and Tolerability of Oral Semaglutide in Subjects With Hepatic Impairment (NCT02016911) | Novo Nordisk A/S | 2013-12-12 |
| Study of Controlled Human Malaria Infections to Evaluate Protection After Intravenous or Intramuscular Administration of PfSPZ Vaccine in Malaria-Naive Adults (NCT02015091) | National Institute of Allergy and Infectious Diseases (NIAID) | 2013-12-12 |
| Pharmacokinetics, Safety and Tolerability of Oral Semaglutide in Subjects With Various Degrees of Impaired Renal Function (NCT02014259) | Novo Nordisk A/S | 2013-12-11 |
| Pharmacokinetics of Sugammadex (MK-8616) in Participants With Moderate and Severe Renal Insufficiency (MK-8616-105) (NCT02011490) | Merck Sharp & Dohme LLC | 2013-12-11 |
| Bioavailability Study of Candesartan Cilexetil 8mg Tablet Under Fasting Conditions (NCT02006589) | GlaxoSmithKline | 2013-12-11 |
| A Phase 1B Dose-escalation and Phase 2a Study of Carotuximab (TRC105) in Combination With Pazopanib in Patients With Advanced Soft Tissue Sarcoma (NCT01975519) | Tracon Pharmaceuticals Inc. | 2013-12-10 |
| Safety and Efficacy of AEB071 and EVEROLIMUS in Patients With CD79-mutant or ABC Subtype Diffuse Large B-Cell Lymphoma (NCT01854606) | Novartis Pharmaceuticals | 2013-12-05 |
| Mesenchymal Stromal Cells in Kidney Transplant Recipients (NCT02012153) | Mario Negri Institute for Pharmacological Research | 2013-12-04 |
| Study to Find a Safe Dose and Show Early Clinical Activity of Weekly Nab-paclitaxel in Pediatric Patients With Recurrent/ Refractory Solid Tumors (NCT01962103) | Celgene | 2013-12-04 |
| Pilot Trial of Botulinum Toxin and Occupational Therapy for Writer's Cramp (NCT02015039) | National Institute of Neurological Disorders and Stroke (NINDS) | 2013-12-03 |
| Inhalation Profiling of Idiopathic Pulmonary Fibrosis (IPF) Patients (NCT02058602) | GlaxoSmithKline | 2013-12-03 |
| Combination Checkpoint Inhibitor Plus Erlotinib or Crizotinib for EGFR or ALK Mutated Stage IV Non-small Cell Lung Cancer (NCT01998126) | University of Utah | 2013-12-02 |
| DT2219ARL for Relapsed or Refractory CD19 (+), CD 22 (+) B-Lineage Leukemia Or Lymphoma (NCT00889408) | Masonic Cancer Center, University of Minnesota | 2013-12-02 |
| Back on My Feet: Emotional Recovery From Fall Injury (NCT01998945) | Weill Medical College of Cornell University | 2013-12-01 |
| A Study To Taste Three New Types Of Crizotinib Formulation In Comparison Of An Oral Solution And To Measure The Amount Of Crizotinib In The Body After These Formulations Are Orally Given, Relative To Capsule Formulation (NCT02006277) | Pfizer | 2013-12-01 |
| In Vivo Drug Interaction Pharmacokinetic Study of Tenofovir 1% Gel and Three Commonly Used Vaginal Products (NCT01813162) | CONRAD | 2013-12-01 |
| Sarpogrelate Drug Interaction (NCT02097511) | Ajou University School of Medicine | 2013-12-01 |
| A Five-Treatment-Period Study to Evaluate the Single-Dose Pharmacokinetics and Pharmacodynamics of Avatrombopag in Healthy Japanese and White Subjects (NCT02039076) | Eisai Inc. | 2013-12-01 |
| The Study of Safety, Pharmacokinetics, Pharmacodynamics of Peglamda (Peginterferon Lamda 1) on Healthy Volunteers and the Preliminary Evaluation of Peglamda and Hepasig (Ribavirin) Treatment's Effects on Chronic Hepatitis C Patients (NCT02063607) | Nanogen Pharmaceutical Biotechnology Joint Stock Company | 2013-12-01 |
| Effectiveness of Cannabis in the Treatment of Tinnitus Patients (NCT01969474) | Wolfson Medical Center | 2013-12-01 |
| Pharmacokinetic Comparison of XS003 and Tasigna (NCT02068898) | XSpray Microparticles | 2013-12-01 |
| Artefill for the Treatment of HIV-associated Facial Lipoatrophy (NCT02009462) | Gerald Pierone, Jr. M.D. | 2013-12-01 |
| The Phase I Clinical Study to Evaluate the Pharmacokinetics of Dw1029M in Healthy Male Volunteer (NCT02004327) | Dong Wha Pharmaceutical Co. Ltd. | 2013-12-01 |
| Safety Study of Mocetinostat in Combination With Azacitidine in Subjects With MDS (NCT02018926) | Mirati Therapeutics Inc. | 2013-12-01 |
| Safety and Efficacy of PG101 for Dry Eye Syndrome (NCT02078661) | Rhodes Pharmaceuticals, L.P. | 2013-12-01 |
| A Study to Assess the Relative Bioavailability of 7 Test Tablet Formulations of JNJ-56021927 With Respect to the Capsule Formulation of JNJ-56021927 in Healthy Male Participants (NCT02031666) | Aragon Pharmaceuticals, Inc. | 2013-12-01 |
| The Pharmacokinetics of Extended Duration High-dose Cefixime for the Decreased Susceptibility of Neisseria Gonorrhoeae: A Phase I Pilot Study (NCT01949363) | National Institute of Allergy and Infectious Diseases (NIAID) | 2013-12-01 |
| Fecal Transplant for Pediatric Patients Who Have Recurrent C-diff Infection (NCT02134392) | Jonathan Gisser | 2013-12-01 |
| Prevention of Macular Edema In Patients With Diabetic Retinopathy Undergoing Cataract Surgery (NCT01988246) | Rishi Singh | 2013-12-01 |
| Evaluation of KX2-391 in Elderly Subjects With Acute Myeloid Leukemia (AML) (NCT01397799) | Kinex Pharmaceuticals Inc. | 2013-12-01 |
| Revlimid / All-Trans Retinoic Acid (ATRA) / Dexamethasone in Relapsed/Refractory Multiple Myeloma (NCT01985477) | M.D. Anderson Cancer Center | 2013-12-01 |
| Pharmacokinetics and Safety of Solithromycin Capsules in Adolescents (NCT01966055) | Melinta Therapeutics, Inc. | 2013-12-01 |
| A Phase 1, Open-label Safety Study of NKA in Patients With Type 2 Diabetes (NCT02008851) | Tengion | 2013-12-01 |
| Effect of Using Whey Protein and Creatine Supplements on Muscular Strength in Weight-training Adult Males (NCT02094781) | GlaxoSmithKline | 2013-12-01 |
| Effect of Neomycin on the Pharmacokinetics of Regorafenib (NCT02001909) | Bayer | 2013-12-01 |
| Safety and Systemic Exposure Study of BL-7010 in Well-Controlled Celiac Patients. (NCT01990885) | BioLineRx, Ltd. | 2013-12-01 |
| A Study of the Safety and Effectiveness of LY3053102 in Participants With Type 2 Diabetes (NCT02020616) | Eli Lilly and Company | 2013-12-01 |
| Combination of Icotinib and Gemcitabine as First-line Treatment in Pancreatic Cancer (NCT02024633) | Betta Pharmaceuticals Co., Ltd. | 2013-12-01 |
| Phase I Rising-dose Study to Assess Tolerability, Safety, Pharmacokinetics, Pharmacodynamics of AR09 (NCT02027155) | Arbor Pharmaceuticals, Inc. | 2013-12-01 |
| SARC023: Ganetespib and Sirolimus in Patients With MPNST (Malignant Peripheral Nerve Sheath Tumors) (NCT02008877) | Sarcoma Alliance for Research through Collaboration | 2013-12-01 |
| Oncolytic HSV-1716 in Treating Younger Patients With Refractory or Recurrent High Grade Glioma That Can Be Removed By Surgery (NCT02031965) | Pediatric Brain Tumor Consortium | 2013-12-01 |
| Haplo-identical SCT for High Risk (HR) Hematologic Malignancies w/Post-Transplant In-Vivo T-cell Depletion (NCT02053545) | Ann & Robert H Lurie Children's Hospital of Chicago | 2013-12-01 |
| Single Dose Morphine and Fentanyl Added to Intrathecal Mixture on Orthopedics Patients With Undiagnosed Obstructive Sleep Apnea (NCT02014714) | University of Malaya | 2013-12-01 |
| Rapid Delivery of Autologous Bone Marrow Derived Stem Cells in Acute Myocardial Infarction Patients. (NCT01536106) | TotipotentRX Cell Therapy Pvt. Ltd. | 2013-12-01 |
| Pharmacokinetic Study of Peginterferon Beta-1a in Japanese and Caucasian Adult Healthy Participants. (NCT01978652) | Biogen | 2013-12-01 |
| A Study of Insulin Peglispro in Healthy Male Japanese Participants (NCT01995526) | Eli Lilly and Company | 2013-12-01 |
| Development of Ibudilast for Alcohol Use Disorder (NCT02025998) | University of California, Los Angeles | 2013-12-01 |
| Alpha-1 Anti-Trypsin (AAT) Treatment in Acute Myocardial Infarction (NCT01936896) | Virginia Commonwealth University | 2013-12-01 |
| Study to Evaluate the Efficacy and Safety of Oxabact (OC5) in Patients With Primary Hyperoxaluria (NCT02012985) | OxThera | 2013-12-01 |
| Comparison of Two Formulations of AZD5363 and the Effect of Food on Pharmacokinetic Exposure, Safety and Tolerability (NCT01895946) | AstraZeneca | 2013-12-01 |
| Anti-Influenza Hyperimmune Intravenous Immunoglobulin Pilot Study (INSIGHT 005: Flu-IVIG Pilot) (NCT02008578) | National Institute of Allergy and Infectious Diseases (NIAID) | 2013-12-01 |
| A Phase 1b Study of LAPS-Exendin in Subjects of Type 2 Diabetes Mellitus (NCT02059564) | Hanmi Pharmaceutical Company Limited | 2013-12-01 |
| Intraperitoneal Docetaxel With Cisplatin and TS-ONE for Gastric Cancer With Peritoneal Carcinomatosis (NCT02024841) | The University of Hong Kong | 2013-12-01 |
| Study of a DNA-based Venezuelan Equine Encephalitis Virus DNA Vaccine Administered by Electroporation in Healthy Volunteers (NCT01984983) | Ichor Medical Systems Incorporated | 2013-12-01 |
| Safety and Feasibility Study of Mesenchymal Trophic Factor (MTF) for Treatment of Osteoarthritis (NCT02003131) | Translational Biosciences | 2013-12-01 |
| A Multiple Dose Pharmacokinetic Study of Perampanel in Korean Healthy Subjects (NCT02020486) | Eisai Co., Ltd. | 2013-12-01 |
| A Study to Assess the Effect of Ketoconazole on the Metabolism of ABT-199 (NCT01969669) | AbbVie | 2013-12-01 |
| A Study of LY2969822 in Healthy Participants (NCT02018887) | Eli Lilly and Company | 2013-12-01 |
| The PK/PD Study of Multiple Dose of SHR3824 in Healthy Volunteers (NCT02361138) | Jiangsu HengRui Medicine Co., Ltd. | 2013-12-01 |
| Clinical Trial to Assess the Pharmacokinetic Characteristics of Lodivixx Tab. 5/160mg in Healthy Male Subjects (N=27) (NCT03648333) | Hanlim Pharm. Co., Ltd. | 2013-12-01 |
| A Clinical Study to Evaluate the Safety and Efficacy of Mesenchymal Stem Cells in Liver Cirrhosis (NCT01877759) | Chaitanya Hospital, Pune | 2013-12-01 |
| Recombinant Human Hyaluronidase in Treating Lymphedema in Patients With Cancer (NCT01928030) | Stanford University | 2013-12-01 |
| A Study Evaluating Veliparib as a Single Agent or in Combination With Chemotherapy in Subjects With Solid Tumors (NCT02033551) | AbbVie | 2013-12-01 |
| Single Radiolabeled Dose Study to Investigate the Absorption, Metabolism and Excretion of [14C]-ETC-1002 (NCT02044627) | Esperion Therapeutics, Inc. | 2013-12-01 |
| Neoadjuvant Chemoradiotherapy With CRLX-101 and Capecitabine for Rectal Cancer (NCT02010567) | UNC Lineberger Comprehensive Cancer Center | 2013-12-01 |
| A Clinical Study to Investigate the Effects of Creatine Supplementation on Muscle Energetics and Cognitive Function in Young Healthy Male Athletes and an Ageing Population (NCT02058654) | GlaxoSmithKline | 2013-12-01 |
| Metabolic Availability of Lysine From White Maize (NCT02018575) | The Hospital for Sick Children | 2013-12-01 |
| IVAC MUTANOME Phase I Clinical Trial (NCT02035956) | BioNTech RNA Pharmaceuticals GmbH | 2013-12-01 |
| Dose-Finding and Safety Study for Oral Single-Agent to Treat Advanced Malignancies (NCT02030067) | Processa Pharmaceuticals | 2013-12-01 |
| The Efficacy and Safety of Periocular Acupoint Stimulation on Myopia Progression in Children (NCT02064660) | Korean Medicine Hospital of Pusan National University | 2013-12-01 |
| A Pilot, Prospective, Non-randomized Evaluation of the Safety of Anakinra Plus Standard Chemotherapy (NCT02021422) | Baylor Research Institute | 2013-12-01 |
| Comparison of PK After Administration of HCP1201 and Co-administration of Metformin SR 750mg and Rosuvastatin 10mg (NCT02026817) | Hanmi Pharmaceutical Company Limited | 2013-12-01 |
| A Single Dose Study Of PF-06678552 In Healthy Subjects (NCT01992614) | Pfizer | 2013-12-01 |
| Safety and Immunogenicity of a Four Influenza Vaccines in Children Ages 6 Months Old to Less Than 48 Months Old (NCT02035696) | Seqirus | 2013-12-01 |
| Phase I Study of Milatuzumab for Graft Versus Host Disease (NCT01663766) | Gilead Sciences | 2013-12-01 |
| An Individualized Anti-Cancer Vaccine Study in Patients With HCC (NCT01995227) | Mirror Biologics, Inc. | 2013-12-01 |
| A Phase I/II to Assess Safety, Tolerability and Efficacy of DL-lactic Acid Syrup in Children With Recurrent Tonsillitis (NCT01988558) | Yali Pharmaceuticals | 2013-12-01 |
| Study of Aflibercept as Maintenance Therapy Following Induction With Aflibercept in Combination With XELOX, as First-Line Treatment for Metastatic Colorectal Cancer Patient (NCT01955629) | Sanofi | 2013-12-01 |
| A Phase I Study in Healthy Volunteers to Assess the Effect of Cytochrome3A4 (CYP3A4) Inhibitors (Diltiazem and Itraconazole) on the Pharmacokinetics (PK) of AZD3293 and the Effects of AZD3293 on the Pharmacokinetics of Midazolam, a Cytochrome 3A4 and Cytochrome 3A5 (CYP3A4/CYP3A5) Substrate (NCT02010970) | AstraZeneca | 2013-12-01 |
| An N-of-1 Study of Homeopathic Treatment of Fatigue in Patients Receiving Chemotherapy (NCT01983592) | The Canadian College of Naturopathic Medicine | 2013-12-01 |
| A Clinical Study to Explore Biomarkers for Drug-induced Liver Injury (DILI) (NCT02143323) | Seoul National University Hospital | 2013-12-01 |
| Study to Assess the Effect of Rifampicin (CYP Inducer) on Blood Levels and Safety of Olaparib in Patients With Advanced Solid Tumours (NCT01929603) | AstraZeneca | 2013-12-01 |
| A Pilot Study of Dociparstat Sodium (ODSH) in Acute Myeloid Leukemia (NCT02056782) | Jazz Pharmaceuticals | 2013-12-01 |
| Investigation of [6R] 5,10-methylenetetrahydrofolate (Arfolitixorin) as Rescue Therapy for Osteosarcoma Patients Treated With HDMTX. (NCT01987102) | Isofol Medical AB | 2013-12-01 |
| A Pilot Study Using Placenta Derived Decidual Stromal Cells for Toxicity and Inflammation With Special Focus to the Allogeneic Hematopoietic Cell Transplantation Setting (NCT02175303) | Karolinska Institutet | 2013-12-01 |
| Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Single Intravenous and Multiple Subcutaneous and Intravenous Doses of PF-06480605 in Healthy Subjects. (NCT01989143) | Telavant, Inc. | 2013-12-01 |
| A Double-blinded, Randomised, Two -Period Crossover Euglycemic Clamp Trial Investigating the Pharmacokinetics, Glucodynamics and Safety of BioChaperone Insulin Lispro and Insulin Lispro (Humalog®) in Subjects With Type 1 Diabetes (NCT02029924) | Adocia | 2013-12-01 |
| A Study to Assess the Safety, Pharmacokinetics and Immunogenicity of CR8020 in Japanese Healthy Participants (NCT02015533) | Janssen Pharmaceutical K.K. | 2013-12-01 |
| Clinical Trial Phase I/II Prospective, Open Nonrandomized for Treatmen of Postoperative Air Leak After Lung Resection in High Risk Patients Through the Administration of Mesenchymal Autologous Cells (NCT02045745) | Red de Terapia Celular | 2013-12-01 |